114 | SYSTEMATIC INVESTIGATION OF DISEASE‐ AND GENOTYPE‐SPECIFIC VULNERABILITIES IN PRIMARY BLOOD CANCER USING HIGH‐THROUGHPUT EX VIVO DRUG SCREENING.

Saved in:
Bibliographic Details
Title: 114 | SYSTEMATIC INVESTIGATION OF DISEASE‐ AND GENOTYPE‐SPECIFIC VULNERABILITIES IN PRIMARY BLOOD CANCER USING HIGH‐THROUGHPUT EX VIVO DRUG SCREENING.
Authors: Hofer, K. D., Scheinost, S., Ben‐Taarit, L., Hüllein, J., Walther, T., Putzker, K., Sellner, L., Kühn, M. W., Kindler, T., Nguyen‐Khac, F., Maull, M. Crespo, Bosch, F., Theocharides, A., Manz, M. G., Bourquin, J., Bornhauser, B., Dietrich, S., Lewis, J., Huber, W., Lu, J., et al
Source: Hematological oncology 2025 Supplement; Vol. 43.
Journal Info: Publisher: Wiley-Blackwell ISSN: 0278-0232
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1099-1069
DOI:10.1002/hon.70093_114